Similar articles

• Heart transplantation, euthyroid sick syndrome, and triiodothyronine replacement.

  Novitzky D. Novitzky D. J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 2):S196-8. J Heart Lung Transplant. 1992. PMID: 1515440 Review. No abstract available.
• Thyroid hormone in cardiac surgery.

  Ranasinghe AM, Bonser RS. Ranasinghe AM, et al. Vascul Pharmacol. 2010 Mar-Apr;52(3-4):131-7. doi: 10.1016/j.vph.2009.11.004. Epub 2009 Nov 27. Vascul Pharmacol. 2010. PMID: 19945545 Review.
• Use of triiodothyronine replacement therapy to reverse donor myocardial dysfunction: creating a larger donor pool.

  Jeevanandam V, Todd B, Hellman S, Eldridge C, McClurken J, Addonizio VP. Jeevanandam V, et al. Transplant Proc. 1993 Dec;25(6):3305-6. Transplant Proc. 1993. PMID: 8266553 No abstract available.
• Effects of substitutive triiodothyronine therapy on intracellular nucleotide levels in donor organs.

  García-Fages LC, Antolín M, Cabrer C, Talbot R, Alcaraz A, Lozano F, Manyalich M. García-Fages LC, et al. Transplant Proc. 1991 Oct;23(5):2495-6. Transplant Proc. 1991. PMID: 1926450 No abstract available.
• Results of hormonal therapy in human brain-dead potential organ donors.

  Novitzky D, Cooper DK. Novitzky D, et al. Transplant Proc. 1988 Oct;20(5 Suppl 7):59-62. Transplant Proc. 1988. PMID: 3055561 No abstract available.